Please enable JavaScript
Powered by Benchmark International Archives - Page 1353 of 1794 - Matribhumi Samachar English
Saturday, January 03 2026 | 05:52:31 AM
Home / International (page 1353)

International

Impact Development Group Inc. Announces Financial Results for Year Ended December 31, 2024

Toronto, Ontario–(Newsfile Corp. – April 9, 2025) – Impact Development Group Inc. (TSXV: IMPT) (“Impact”, “IDG” or the “Company”), a leading Panamanian developer of affordable housing solutions, has released its financial results for the year ended December 31, 2024. IDG’s audited consolidated financial statements (the “Financial Statements”) and related management’s …

Read More »

Zentek Announces Closing of $2,000,000 Non-Brokered Private Placement of Debenture Units

Guelph, Ontario–(Newsfile Corp. – April 9, 2025) –  Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) (“Zentek” or the “Company”), announces that it has closed a non-brokered private placement (the “Offering”) of debenture units (the “Debenture Units”) through the issuance of 2,000 Debenture Units for gross proceeds of $2,000,000. Each Debenture Unit consists …

Read More »

Blacksteel Energy Inc. Announces April 30, 2024, Reserves Update

Calgary, Alberta–(Newsfile Corp. – April 9, 2025) – Blacksteel Energy Inc. (“Blacksteel” or the “Company”) announces that it has filed its independent reserves report for the year ended April 30, 2024. GLJ Ltd. (“GLJ”) conducted an independent reserves evaluation and prepared the Company’s reserve report (the “Reserve Report”) dated March …

Read More »

Kovo+ Holdings Inc. Provides Updates on Private Placements and Warrant Extension

Vancouver, British Columbia–(Newsfile Corp. – April 9, 2025) – Kovo+ Holdings Inc. (formerly Kovo HealthTech Corporation) (TSXV: KOVO) (“Kovo” or the “Company”) is pleased to announce that it has received conditional approval of the TSX Venture Exchange (“TSXV”) in connection with its previously announced non-brokered private placement of units (“Units”) …

Read More »

NervGen Provides Quarterly “At-The-Market” Equity Program Update

Vancouver, British Columbia–(Newsfile Corp. – April 9, 2025) – NervGen Pharma Corp. (TSXV: NGEN) (OTCQB: NGENF) (“NervGen” or the “Company”), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today provided a quarterly update with respect to the Company’s previously announced at-the-market equity program (the “ATM Program”) launched on December …

Read More »